Microglia are damage sensors for the central nervous system (CNS), and the phagocytes responsible for routine non-inflammatory clearance of dead brain cells 1 . Here we show that the TAM receptor tyrosine kinases Mer and Axl 2 regulate these microglial functions. We find that adult mice deficient in microglial Mer and Axl exhibit a marked accumulation of apoptotic cells specifically in neurogenic regions of the CNS, and that microglial phagocytosis of the apoptotic cells generated during adult neurogenesis 3,4 is normally driven by both TAM receptor ligands Gas6 and protein S 5 . Using live two-photon imaging, we demonstrate that the microglial response to brain damage is also TAM-regulated, as TAM-deficient microglia display reduced process motility and delayed convergence to sites of injury. Finally, we show that microglial expression of Axl is prominently upregulated in the inflammatory environment that develops in a mouse model of Parkinson's disease 6 . Together, these results establish TAM receptors as both controllers of microglial physiology and potential targets for therapeutic intervention in CNS disease.
were required for clearance of the apoptotic cells generated during adult neurogenesis, which occurs in the subgranular zone of the dentate gyrus and the subventricular zone (SVZ) abutting the lateral ventricle, and produces neurons that integrate into the hippocampus and olfactory bulb, respectively 3 . We used the CLARITY imaging method with Cx3cr1 GFP/+ mice to show that the SVZ, like the rest of the CNS 1 , is tiled by microglia (see Supplementary Video 1) . During neurogenesis in the mouse subgranular zone, ~ 80% of cells die within 8 days of their birth 4 . These dead cells are rapidly cleared by microglia, such that apoptotic cells are difficult to detect in a healthy brain 4 . Indeed, when we examined SVZ sections from Cx3cr1 GFP/+ brains using cleaved caspase 3 (cCasp3) as a marker of apoptotic cells 5 , we were unable to detect even a single cCasp3 + cell in many sections (Fig. 1a ). In marked contrast, the SVZ from Axl −/− Mertk −/− Cx3cr1 GFP/+ mice was studded with cCasp3 + cells (Fig. 1a) , which were negative for the neuronal marker NeuN (Fig. 1a ). Uncleared apoptotic cells extended into the Axl −/− Mertk −/− rostral migratory stream (RMS), the pathway through which newborn cells migrate to the olfactory bulb ( Fig. 1b) . Apoptotic cells were confined to Axl −/− Mertk −/− neurogenic regions, however, and were not seen elsewhere in the CNS (Extended Data Fig. 2 ). Microglia in the Axl −/− Mertk −/− SVZ and RMS displayed elevated expression of GFP (controlled by the Cx3cr1 promoter), Iba1, and Siglec-1 (CD169), as well as an 'activated amoeboid' morphology 1 (Fig. 1a, c) .
Consistent with the minimal expression of Axl, no accumulation of apoptotic cells was detected in the Axl −/− SVZ (Extended Data Fig. 3a ). In contrast, the Mertk −/− SVZ contained many cCasp3 + apoptotic cells, although this number was around fourfold lower than that seen in Axl −/− Mertk −/− double mutants (Extended Data Fig. 3a ). We counted 733 ± 359 (± s.e.m.) cCasp3 + cells per mm 2 in sections of the Mertk −/− SVZ, and 2942 ± 262 cCasp3 + cells per mm 2 in the Axl −/− Mertk −/− SVZ. This synergistic effect of an Axl mutation on the background of an existing Mertk mutation has been noted previously 2, 5, 8, 9, 12 .
We demonstrated that accumulation of apoptotic cells in the Mertk −/− SVZ and RMS is due to the loss of Mer specifically from microglia, by analysing a new mouse line carrying conditional floxed alleles of the Mertk gene (Extended Data Fig. 4 ; see Methods) crossed to a tamoxifen-inducible oestrogen receptor (ER) Cre driver controlled by the Cx3cr1 promoter 24 . In the absence of tamoxifen (upon vehicle injection alone), Mer was present in Cx3cr1 CreER/+ Mertk fl/fl Iba1 + microglia (Extended Data Fig. 5a ), and there were no cCasp3 + apoptotic cells in the SVZ or RMS (Fig. 1d ). However, 1 week after tamoxifen injection, microglial Mer expression was lost (Extended Data Fig. 5a ), and accumulation of apoptotic cells, comparable to that seen in Mertk −/− mice, was detected in the Cx3cr1 CreER/+ Mertk fl/fl SVZ and RMS ( Fig. 1d ). Microglia remained Mer-negative (Extended Data Fig. 5a ) and accumulation of apoptotic cells was maintained at 3 and 7 weeks after tamoxifen injection ( Fig. 1d ), by which time most Cx3cr1 CreER/+ gene-deleted cells outside the CNS have been replaced by monocytes and/or haematopoietic progenitors 24 . Mer expression in brain microvascular endothelial cells 23 , an important Mer reservoir in the CNS 25 , persisted following tamoxifen treatment (Extended Data Fig. 5b ).
We assessed the consequences of defective clearance of apoptotic cells on neurogenesis by pulse labelling dividing cells in the SVZ of adult mice with bromodeoxyuridine (BrdU), and then counting BrdU + cells that had migrated to the granule cell and glomerular layers of the olfactory bulb 35 days after the pulse ( Fig. 2a, b ). We found that accumulation of apoptotic cells in the Axl −/− Mertk −/− SVZ did not reduce the number of BrdU + cells in the olfactory bulb, none of which were apoptotic (Extended Data Fig. 2c ) or microglia ( Fig. 2c ). Indeed, we observed a notable ~ 70% increase in the number of BrdU + cells in the Axl −/− Mertk −/− olfactory bulb relative to the wild type ( Fig. 2b) . This translated to an increased cellular density in the combined granule cell and glomerular layers of the Axl −/− Mertk −/− olfactory bulb, from 87.7 ± 2.2 nuclei per 10 4 μ m 2 (± s.e.m.) in wild type to 99.8 ± 2.4 for the double mutants (n = 6 for both genotypes; P = 0.004). These results are consistent with the possibility that a fraction of phosphatidylserine (PtdSer)-expressing, but nonetheless viable, SVZ-derived cells are normally 'eaten alive' by microglia, in a process termed 'phagoptosis' 26 , that this process occurs continuously in a non-pathogenic environment, 
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and that it is TAM-dependent. Many of the BrdU + cells that had migrated to the Axl −/− Mertk −/− olfactory bulb were NeuN + (Fig. 2d ), and some expressed markers appropriate to their location (Extended Data Fig. 6a, b ).
Genetic analyses in vivo indicated that both protein S (Pros1) and Gas6 function as Mer agonists for engulfment of apoptotic cells by microglia. The Gas6 −/− SVZ displayed a wild-type phenotype (Extended Data Fig. 3b ), as did the SVZ of Gas6 −/− Pros1 fl/− mice, in which one Pros1 allele is floxed with loxP sites and the other is inactivated 27 . (The complete Pros1 −/− knockout is embryonic lethal 27 .) In contrast, Gas6 −/− Mertk −/− mice displayed a marked accumulation of cCasp3 + cells in the SVZ and RMS, comparable to that seen in Axl −/− Mertk −/− mice (Extended Data Fig. 3c ). We counted 3,638 ± 282 (± s.e.m.) cCasp3 + cells per mm 2 in the Gas6 −/− Mertk −/− mice SVZ. This is consistent with the fact that Pros1, the only TAM ligand remaining in the Gas6 −/− Mertk −/− mice, does not activate Axl 5 , the only microglial TAM receptor remaining in these mice. Thus, as for Mer-dependent phagocytosis in the retina 10 , only half of the wild-type level of only a single TAM ligand was sufficient to drive wild-type levels of microglial phagocytosis.
We also quantified phagocytosis of apoptotic cells by microglia cultured from Cx3cr1 GFP/+ mice 12 (Extended Data Fig. 7a ). When incubated with apoptotic cells 12 in medium containing 10% serum, where Pros1 is present at ~ 30 nM, wild-type microglia were exceptionally active phagocytes (Extended Data Fig. 7b ). Phagocytosis was reduced in Axl −/− Mertk −/− cells (Extended Data Fig. 7b ). In serum-free medium, phagocytosis of apoptotic cells was further reduced, which was mostly TAM-dependent (Extended Data Fig. 7c, d ). (This TAM dependence is consistent with the fact that microglia express endogenous Gas6 and Pros1 mRNA 17 .) When we supplemented serum-free medium with Pros1 or Gas6, we found that both ligands stimulated TAMdependent phagocytosis (Extended Data Fig. 7c, d ). Cultured astrocytes engulfed less apoptotic cells than microglia, and this phagocytosis could be stimulated only modestly by Gas6 (Extended Data Fig. 7e ). Stimulation of microglial phagocytosis by both Gas6 and Pros1 demonstrates that it is mediated principally by Mer, as Axl is activated only by Gas6 5, 12 .
Although microglia in an uninjured brain are essentially fixed in position, their processes are in constant motion, and survey the entirety of the CNS parenchyma every few hours 28 . As process extension is also required for phagocytosis 12 , we asked if TAM signalling regulates microglial extension velocity. We used in vivo two-photon microscopy to measure the movement of microglial processes outside of the neurogenic regions, in the visual cortex of wild-type Cx3cr1 GFP/+ and Axl −/− Mertk −/− Cx3cr1 GFP/+ mice (Supplementary Videos 2 and 3). Selected video stills, with individual wild-type and Axl −/− Mertk −/− processes tracked during imaging, are shown in Fig. 3a . These measurements demonstrated that Axl −/− Mertk −/− microglia, in an uninjured brain, display a ~ 19% reduction in process extension velocity relative to wild type (Fig. 3b ). We also assessed whether TAM signalling was required for microglial responses to injury. We disrupted the bloodbrain barrier at the level of individual capillaries with a laser lesion 28 , and then measured the velocity of microglial process extension towards the lesion site using live two-photon imaging (Supplementary Videos 4 and 5). Selected video stills, with individual extensions towards the lesion tracked in wild-type and Axl −/− Mertk −/− Cx3cr1 GFP/+ brains, are shown in Fig. 3c . We found that extension towards the laser lesion was ~ 39% slower in the Axl −/− Mertk −/− microglia (Fig. 3d ). These results demonstrate that routine microglial process activity and the response to injury are both regulated by TAM. They are consistent with the finding that Mertk −/− macrophages exhibit compromised cellular migration and a disrupted cytoskeleton in vitro 29 .
For many macrophages, Axl and Mer segregate to inflammatory and tolerogenic environments, respectively 12 . Inflammatory stimuli such as polyinosinic-polycytidylic acid (poly(I:C)) and interferon γ(IFNγ) upregulate Axl expression, whereas immunosuppressive drugs such as dexamethasone upregulate Mer 12 . We saw similar responses in cultured microglia (Extended Data Fig. 8a, b ). As Axl is an inflammatory marker, we asked whether its microglial expression might be elevated in neurodegenerative disease 1 , and examined a transgenic mouse model of Parkinson's disease. In this model, an alanine 53 to threonine (A53T) mutated form of human α -synuclein (SNCA A53T ), which leads to a hereditary form of Parkinson's disease, is expressed in neurons, most prominently in the spinal cord, under the control of the mouse Thy1 promoter 6 . This transgenic expression results in late-onset neurodegeneration, and death at 8-10 months 6 . Measurement of a panel of inflammatory marker mRNAs demonstrated that the spinal cords, and to a lesser extent the brains, of aged Thy1-SNCA A53T transgenic mice displayed elevation of these markers, whereas inflammation was undetectable in the spleen (Fig. 4a , Extended data Fig. 8c ).
The aged transgenic spinal cord, where SNCA A53T expression is high (ref. 29 and Fig. 4b ), showed markedly elevated expression of Iba1 (Fig. 4b ). We also detected upregulation of both Axl and soluble Axl (sAxl) ectodomain, an inflammatory marker 12 , in the transgenic cord ( Fig. 4c and Extended Data Fig. 8d ). In contrast, Axl upregulation was undetectable in Thy1-SNCA A53T spleen and minimal in brain (Extended Data Fig. 8d ). No change in Mer expression was detected in the spleen Letter reSeArCH of the transgenic mice (Extended Data Fig. 8d ), with only a very modest increase in the spinal cord ( Fig. 4c and Extended Data Fig. 8e ). Axl induction in the Thy1-SNCA A53T spinal cord was exclusively associated with Iba1 + microglia (Fig. 4d ). Expression of SNCA A53T in spinal motor neurons (ref. 29 and Fig. 4b ) leads to progressive ataxia, paralysis, and death, with an onset at ~ 120 days in the transgenic population ( Fig. 4e) . A 50% reduction in Mer and Axl resulted in no change in this time course, but the loss of both receptors modestly extended survival (Fig. 4e ). We do not know the reason for this modest life extension; however, we speculate that wild-type microglia may execute TAM-dependent 'phagoptotic' engulfment 26 of distressed, PtdSer-displaying motor neurons, thereby speeding up the death of the mice. Together, the above results identify Mer and Axl as regulators of multiple features of microglial physiology. The elevation in microglial Axl that we document in the Thy1-SNCA A53T spinal cord is in keeping with the demonstration that Axl is an inflammatory response receptor in macrophages 12 , and that elevated levels of sAxl are observed during multiple human disease and trauma states (ref. 8 , and references therein). In this regard, we note that a recent longitudinal study in humans has identified elevated Axl in CSF as among the most reliable indicators of the early appearance of Aβ pathology and the subsequent development of Alzheimer's disease 30 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Letter reSeArCH Immunocytochemistry. Cells were fixed for 10 min in 4% PFA/4% sucrose in PBS, washed with PBS, incubated for 10 min in 100 mM glycine, permeabilized for 5 min in 0.2% Triton-X100 in PBS, washed with PBS, and nonspecific binding was then blocked by 40 min incubation in blocking buffer (2% IgG-free BSA in PBS). Coverslips were incubated for 1 h at 22-24 °C with primary antibody diluted in blocking buffer, washed five times in PBS, and then incubated for 1 h at 22-24 °C in the dark with Hoechst stain and fluorophore-coupled donkey secondary antibody (identified above) diluted in blocking buffer. Coverslips were washed and mounted on slides with Fluoromount-G (SouthernBiotech) and stored at 4 °C. Images were acquired with a Zeiss LSM 710 confocal microscope using Plan-Apochromat 40× and 63× objectives. CLARITY imaging. One cerebral hemisphere from a Cx3cr1 GFP/+ mouse was cleared using CLARITY protocols, essentially as described 34 . Rather than electrophoretic clearing, samples were incubated at 37 °C and passively cleared over 3 weeks by daily replacement of the clearing solution. A 1 mm 3 block of tissue adjacent to the lateral ventricle of Cx3cr1 GFP/+ mice, in the region containing the SVZ, was imaged using a Zeiss LSM 710 confocal microscope. Fiji software was used to assemble images. Immunoblot. Cultured cells were washed with ice-cold DPBS and lysed on ice in 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 1 mM EDTA, 1% Triton-X100, 0.27 M sucrose, and protease and phosphatase inhibitors (Roche). Tissues were snapfrozen in liquid nitrogen before lysis. For immunoblot analysis, equal amounts of protein in LDS sample buffer (Invitrogen) were separated by electrophoresis through 4-12% Bis-Tris polyacrylamide gels (Novex, Life Technologies) and transferred to PVDF membranes (Millipore). For Axl immunoprecipitation, tissue lysates were precleared overnight at 4 °C with Protein G-Sepharose (Invitrogen). This was then removed and lysates were incubated for 2 h with 0.2 μ g anti-Axl (M20) for 0.5 mg protein in cell lysate. Fresh Protein G-Sepharose was added for 2 h and immunoprecipitates were washed twice with 1 ml of lysis buffer containing 0.5 M NaCl and once with 1 ml of 50 mM Tris-HCl (pH 7.5). Immunoprecipitates were eluted in LDS buffer, separated by electrophoresis through polyacrylamide gels and transferred to PVDF membranes. Nonspecific binding was blocked with TBST (50 mM Tris-HCl (pH 7.5), 0.15 M NaCl and 0.1% Tween-20) containing 5% BSA, and membranes were incubated overnight at 4 °C with primary antibodies diluted in blocking buffer. Blots were then washed in TBST and incubated for 1 h at 22-24 °C with secondary horseradish peroxidase-conjugated antibodies in 5% skim milk in TBST. After repeating the washes, signal was detected with enhanced chemiluminescence reagent. Reverse transcription (RT)-qPCR. Total cellular RNA was isolated with an RNeasy Mini Kit according to the manufacturer's instructions (Qiagen).
DNA was removed by on-column digestion with DNase (Qiagen). An RT Transcriptor First Strand cDNA Synthesis Kit (Roche) with anchored oligonucleotide (dT) primers (Roche) was used for reverse transcription. Quantitative PCR was run in a 384-well plate format on a ViiA 7 Real-Time PCR System (Applied Biosystems) with 2 × SYBR Green PCR Master Mix (Applied Biosystems). Primers are listed in Supplementary Table 1 . Expression was analysed by the threshold cycle (∆ ∆ C t ). Microglia and astrocyte culture. Postnatal day 30 (P30) to P50 mice (Cx3cr1 GFP/+ , Axl −/− Mertk −/− Cx3cr1 GFP/+ ) brains were dissociated using Neural Dissociation kit, Postnatal Neurons and the gentleMACS dissociator according to the manufacturer's instructions (Miltenyi). Single cell suspensions were resuspended in 30% Percoll in HBSS solution and centrifuged 15 min at 700 g to remove myelin. Cells were grown for 7 days in DMEM-F12 with 10% fetal bovine serum (FBS) and 1% penicillin/ streptomycin before being processed for immunostaining or phagocytosis assay. Cytosine β -d-arabinofuranoside (Ara-C, 5 μ M) was added after 5 days in vitro to limit fibroblast proliferation. When astrocytes were also isolated, microglia were first purified using C11b MicroBeads (Miltenyi) and grown for 7 days in DMEM-F12 with 10% FBS and 1% penicillin/streptomycin while astrocytes were grown for 10 days in MACS Neuro Medium with 2% MACS NeuroBrew-21 and 1% penicillin/streptomycin. Phagocytosis assay. For the generation of apoptotic cells, thymocytes were isolated from 3-to 6-week-old mice, red blood cells were lysed with ACK buffer and remaining cells were incubated for 6 h in RPMI medium containing 5% FBS and 2 μ M dexamethasone to induce apoptosis. This routinely resulted in 70% apoptotic and ≤ 5% necrotic cells. Apoptotic cells were then stained for 30 min with100 ng ml −1 pHrodo-s.e. (Invitrogen) as described previously 12, 35, 36 . Labelled cells were washed twice in PBS containing 1% BSA (to block remaining pHrodo-SE) and 1 mM EDTA (to remove any bound Gas6 and protein S) and once with DMEM. Apoptotic cells were then incubated for 10 min with recombinant mouse Gas6 or purified human protein S, added to microglia or astrocyte cultures at a ratio of 10:1 (apoptotic cells:phagocytes), and incubated for 1 h at 37 °C. Microglia or astrocytes were then briefly washed in DPBS, incubated for 10 min at 37 °C in trypsin (0.25%), and then placed on ice and detached by vigorous pipetting. Astrocytes were labelled using anti-ACSA2-APC antibody 37 . Phagocytosis was assessed by flow cytometry with post-acquisition data analysis with FlowJo software (TreeStar). pHrodo fluorescence was measured with excitation at 561 nm and emission filters for phycoerythrin (574-590 nm) on a LSR II (BD Biosciences) at the Flow Cytometry Core of the Salk Institute, as described previously 12 . Microglia were gated as GFP + cells and astrocytes were gated as APC + cells. Two-photon imaging. Adult male mice (3-6 months old) were anaesthetized with isoflurane (1.5-2.5% in 100% oxygen at 0.8-1.0 l min −1 ). Body temperature was kept at 36-37 °C, and hydration status was maintained using subcutaneous physiological saline injections (0.1 ml per 25 g body weight every 1-2 h). For head plate implantation, hair, skin and periosteum overlying the neocortex were removed. After cleaning exposed skull areas, a custom metal head plate was affixed to the skull using OptiBond (31514; Kerr) and dental acrylic (H00335; Coltene Whaledent), keeping the intended imaging area over somatosensory or visual cortex uncovered. A polished and reinforced thinned skull window (~ 2-3-mm diameter; ~ 20-50 μ m remaining bone thickness) was then prepared, as described previously 38, 39 . A movable objective microscope (Sutter Instrument) equipped with a pulsed femtosecond Ti:Sapphire laser (Chameleon Vision II or Ultra II, Coherent), two fluorescence detection channels (565DXCR dichroic, ET525/70M-2P and ET605/70M-2P emission filters, Chroma; H7422-40 GaAsP photomultiplier tubes, Hamamatsu), and a water immersion objective (LUMPlanFL N 40XW 0.8NA; Olympus) was used for two-photon imaging. Imaging was performed as described previously 28, 39 using 920-940 nm centre excitation wavelengths. Average laser powers used for transcranial optical recordings depended on imaging depth (typically ~ 10-30 mW at ~ 150-200 μ m depth from the pia). Images were typically acquired using a 6 Hz frame rate, 256 × 256 pixel resolution and a 5-frame average. Image stacks were acquired every 1.5-2 min for up to 5 h and typically contained 20-30 images per stack with 1 μ m axial image spacing. Fields-of-view had a typical side length of 65-100 μ m. Imaging settings were kept constant during time-lapse recordings. For quantitative image data analysis, ImageJ or Fiji software was used. First, maximum intensity images were produced from individual image stacks. Then, lateral image shifts in timelapse recordings were corrected using a custom-written ImageJ alignment plugin based on the position shift of the peak in cross-correlation images, typically using the first projection image as the reference image. Structural dynamics of individual microglial cell processes was quantified manually using the MTtrackJ plugin in Fiji. Image analysis was done blind with respect to experimental condition. Videos were also created with Fiji. Laser lesion. To target blood vessels for focal laser lesion, blood plasma was stained by tail vein injection of biocytin-TMR (2-5% in saline, T-12921, Life Technologies). Lesions were performed following a baseline recording period of 30-45 min, during which z-stacks were acquired as described above. To induce lesions, the Ti:Sapphire laser was transiently tuned to 800 nm and a confined area (8-15 μ m diameter, ~ 1 μ m axial extent) of a horizontally oriented cortical capillary at 150-220 μ m depth was exposed to 70-130 mW for 10-30 s. Laser lesions caused extravasation of dye, indicating disruption of the blood-brain barrier. Following focal lesion, image stack acquisition was resumed using the same laser and recording parameters as during the baseline recording period. Although Supplementary Videos 4 and 5 run for only ~ 12 min (the time required for microglial processes to reach the lesion site), time-lapse recording of the same cortical volume continued for 2-4 h after the lesion. 
